TVRD
Tvardi Therapeutics
TVRD
TVRD
114 hedge funds and large institutions have $296M invested in Tvardi Therapeutics in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 101 → 114 (+13)
0.31% more ownership
Funds ownership: 1.41% → 1.72% (+0.31%)
25% less call options, than puts
Call options by funds: $11.2M | Put options by funds: $15.1M
Holders
114
Holding in Top 10
3
Calls
$11.2M
Puts
$15.1M
Top Buyers
| 1 | +$25.9M | |
| 2 | +$16.5M | |
| 3 | +$15.6M | |
| 4 |
RCP
Rho Capital Partners
New York
|
+$9.2M |
| 5 |
Jennison Associates
New York
|
+$5.52M |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$2.39M | |
| 3 | -$2.1M | |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$1.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.66M |